glp 1 and prostate cancer Targeting obesity, metabolic syndrome, cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology May Patients Receiving GLP-1 Agonists

Bloodwork was "normal." She'd tried the diet that used to work in her forties the one where she just cut bread and the weight came off

We found that ~37% of consumers who are currently on GLP-1s have either slightly or significantly increased their consumption of snack foods in the past 12 months, while ~37% either slightly or significantly reduced their consumption habits

Between 2019 and 2024, prescriptions for GLP-1 drugs rose 587%

In individuals with T2D, epigenetic modifications, specifically increased DNA methylation of the GLP-1R gene, reduce receptor expression, impairing the function of GLP-1 and lowering insulin secretion